中海油(00883.HK)海上大型深水自營氣田陵水17-2氣田投產
中海油(00883.HK)宣佈,中國首個海上大型深水自營氣田陵水17-2氣田已投產。該氣田位於瓊東南盆地北部海域,水深約1,560米,是公司在中國海域自營深水勘探的首個重大油氣發現,天然氣探明地質儲量超過1,000億立方米。
陵水17-2氣田新建一座帶有凝析油儲油功能的半潛式生產平臺及繫泊系統,一套水下生產系統和海底管線,計劃投產生產井11口,預計2022年將實現日產天然氣3.28億立方英尺、凝析油6,751桶的高峯產量,穩產期10年。
中海油表示,該氣田投產後,天然氣將通過海底管線接入國家天然氣管網,成爲滿足粵港瓊地區用氣需求的重要來源之一。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.